임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
37건 표시
- 1상상태 미확인· Type II Diabetes MellitusStudy to Evaluate the Safety and Pharmacokinetics of CKD-379
리드: 종근당
- 1상상태 미확인· Cardiovascular DiseasesClinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions
리드: 종근당
- 1상상태 미확인· Cardiovascular DiseasesClinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions
리드: 종근당
- 1상상태 미확인· AnticoagulantA Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers
리드: 종근당
- 1상상태 미확인· Early PubertyThe Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1
리드: 종근당
- 1상상태 미확인· Chronic Hepatitis bClinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects
리드: 종근당
- 1상상태 미확인· T2DM (Type 2 Diabetes Mellitus)Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393
리드: 종근당
- 1상상태 미확인· AnticoagulantA Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344
리드: 종근당
- 1상상태 미확인· Cardiovascular DiseaseClinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers
리드: 종근당
- 1상상태 미확인· Cardiovascular DiseasesClinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions
리드: 종근당
- 1상상태 미확인· Cardiovascular DiseasesClinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions
리드: 종근당
- 1상상태 미확인· Cardiovascular DiseaseClinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers
리드: 종근당
- 1상상태 미확인· Type 2 DiabetesClinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389
리드: 종근당
- 1상상태 미확인· Type2 Diabetes MellitusA Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396
리드: 종근당
- 1상상태 미확인· Type2 Diabetes MellitusA Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers
리드: 종근당
- 1상상태 미확인· Type2 Diabetes MellitusA Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375
리드: 종근당
- 1상상태 미확인· HypertensionA Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012
리드: 종근당
- 1상상태 미확인· Type 2 Diabetes MellitusThe Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375
리드: 종근당
- 1상상태 미확인· Type 2 Diabetes MellitusPharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults
리드: 종근당
- 1상상태 미확인· Type 2 Diabetes MellitusPharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition
리드: 종근당
- 1상상태 미확인· Type2 Diabetes MellitusPharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults
리드: 종근당
- 1상상태 미확인· DyslipidemiasA Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects
리드: 종근당
- 1상상태 미확인· Type II DiabetesPharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults
리드: 종근당
- 1상상태 미확인· Type II Diabetes MellitusClinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg
리드: 종근당
- 1상상태 미확인· Huntington DiseaseCKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects
리드: 종근당
- 1상상태 미확인· Myeloma, MultipleCKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple Myeloma
리드: 종근당
- 1상상태 미확인· Myeloma, MultipleCKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma
리드: 종근당
- 1상상태 미확인· Diabetes Mellitus, Type IIEvaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin
리드: 종근당
- 1상상태 미확인· Advanced Refractory Solid TumorsNOV120401 (CKD-516 Tablet) for Advanced Solid Tumors
협력: 종근당
- 1상상태 미확인· Essential HypertensionStudy to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg
리드: 종근당
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.